{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T14:24:59Z","timestamp":1753885499098,"version":"3.40.4"},"reference-count":27,"publisher":"AOSIS","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["South African Family Practice"],"DOI":"10.4102\/safp.v65i1.5708","type":"journal-article","created":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T11:29:59Z","timestamp":1690975799000},"source":"Crossref","is-referenced-by-count":1,"title":["Methadone use for acute opioid withdrawal in Tshwane shelters during the COVID-19 lockdown"],"prefix":"10.4102","volume":"65","author":[{"given":"Jo-Marie A.","family":"Siemens","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Urvisha","family":"Bhoora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle Janse","family":"van Rensburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2580","published-online":{"date-parts":[[2023,7,14]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"Morgan N, Daniels W, Subramaney U. A prospective observational study of heroin users in Johannesburg, South Africa: Assessing psychiatric comorbidities and treatment outcomes. Compr Psychiatry. 2019;95:152137. https:\/\/doi.org\/10.1016\/j.comppsych.2019.152137","DOI":"10.1016\/j.comppsych.2019.152137"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Weich L. 'Defeating the dragon' - Can we afford not to treat patients with heroin dependence? SAJP. 2010;16(3):75-79. https:\/\/doi.org\/10.4102\/sajpsychiatry.v16i3.260","DOI":"10.4102\/sajpsychiatry.v16i3.260"},{"key":"ref2","unstructured":"Equity pharmaceuticals guidelines: Methadone [homepage on the Internet]. [cited 2020 Mar 12]. Available from: https:\/\/www.equitypharmaceuticals.co.za\/downloads\/Equity%20Methadone%2012%20March%202020.pdf"},{"key":"ref3","unstructured":"World Drug Report 2020 (United Nations publication, Sales No. E.20.XI.6). London: United Nations; 2020."},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Morgan N, Daniels W, Subramaney U. An inverse relationship between alcohol and heroin use in heroin users post detoxification. Subst Abuse Rehabil. 2020;11:1-8. https:\/\/doi.org\/10.2147\/SAR.S228224","DOI":"10.2147\/SAR.S228224"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Specka M, Lopez Gonzales K, Scherbaum N. Outcomes of comprehensive inpatient opiate detoxification in patients re-admitted to treatment within one year. Psychiatr Prax. 2015;42(1):30-34. https:\/\/doi.org\/10.1055\/s-0033-1349558","DOI":"10.1055\/s-0033-1349558"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Peltzer K, Ramlagan S, Johnson BD, Phaswana-Mafuya N. Illicit drug use and treatment in South Africa: A review. Subst Use Misuse. 2010;45(13):2221-2243. https:\/\/doi.org\/10.3109\/10826084.2010.481594","DOI":"10.3109\/10826084.2010.481594"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Saban A, Flisher A, Laubscher R, London L, Morojele N. The association between psychopathology and substance use: Adolescent and young adult substance users in inpatient treatment in Cape Town, South Africa. Pan Afr Med J. 2014;17(Suppl. 1):8. https:\/\/doi.org\/10.11604\/pamjs.supp.2014.17.1.3044","DOI":"10.11604\/pamjs.supp.2014.17.1.3044"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Mthembi PM, Mwenesongole EM, Cole MD. Chemical profiling of the street cocktail drug 'nyaope' in South Africa using GC-MS I: Stability studies of components of 'nyaope' in organic solvents. Forensic Sci Int. 2018;292:115-124. https:\/\/doi.org\/10.1016\/j.forsciint.2018.08.001","DOI":"10.1016\/j.forsciint.2018.08.001"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Hassamal S, Goldenberg M, Ishak W, Haglund M, Miotto K, Danovitch I. Overcoming barriers to initiating medication-assisted treatment for heroin use disorder in a general medical hospital: A case report and narrative literature review. J Psychiatr Pract. 2017;23(3):221-229. https:\/\/doi.org\/10.1097\/PRA.0000000000000231","DOI":"10.1097\/PRA.0000000000000231"},{"key":"ref10","unstructured":"Kipnis SS, Herron A, Perez J, Joseph H. Integrating the methadone patient in the traditional addiction inpatient rehabilitation program - Problems and solutions. Mt Sinai J Med. 2001;68(1):28-32."},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Chen IM, Huang CL, Yeh BJ, Chien YL. Health service utilization of heroin abusers: A retrospective cohort study. Addict Behav. 2015;45:281-286. https:\/\/doi.org\/10.1016\/j.addbeh.2015.01.042","DOI":"10.1016\/j.addbeh.2015.01.042"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Wegman MP, Altice FL, Kaur S, et al. Relapse to opioid use in opioid-dependent individuals released from compulsory drug detention centres compared with those from voluntary methadone treatment centres in Malaysia: A two-arm, prospective observational study. Lancet Glob Health. 2017;5(2):198-207. https:\/\/doi.org\/10.1016\/S2214-109X(16)30303-5","DOI":"10.1016\/S2214-109X(16)30303-5"},{"key":"ref13","unstructured":"Harm Reduction International. The global state of harm reduction. 6th ed. London: Harm Reduction International, 2018; p. 13."},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Woody GE, Bruce D, Korthuis PT, et al. HIV risk reduction with buprenorphine-naloxone or methadone: Findings from a randomized trial. J Acquir Immune Defic Syndr. 2014;66(3):288-293. https:\/\/doi.org\/10.1097\/QAI.0000000000000165","DOI":"10.1097\/QAI.0000000000000165"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Kenney SR, Bailey GL, Anderson BJ, Stein MD. Heroin refusal self-efficacy and preference for medication-assisted treatment after inpatient detoxification. Addict Behav. 2017;73:124-128. https:\/\/doi.org\/10.1016\/j.addbeh.2017.05.009","DOI":"10.1016\/j.addbeh.2017.05.009"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Kuhlmann T, Specka M, Rhode A, et al. Opioid maintenance for patients in inpatient long-term rehabilitation treatment - Which patients benefit? Psychiatr Prax. 2019;46(5):281-286. https:\/\/doi.org\/10.1055\/a-0883-2690","DOI":"10.1055\/a-0883-2690"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Rhodes T, Closson EF, Paparini S, Guise A, Strathdee S. Towards 'evidence-making intervention' approaches in the social science of implementation science: The making of methadone in East Africa. Int J Drug Policy. 2016;30:17-26. https:\/\/doi.org\/10.1016\/j.drugpo.2016.01.002","DOI":"10.1016\/j.drugpo.2016.01.002"},{"key":"ref18","unstructured":"Weich L, Perkel C, Van Zyl N, Rataemane ST, Naidoo L. Medical management of opioid dependence in South Africa. S Afr Med J. 2008;98(4):280-283."},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Bailey GL, Herman DS, Stein MD. Perceived relapse risk and desire for medication assisted treatment among persons seeking inpatient opiate detoxification. J Subst Abuse Treat. 2013;45(3):302-305. https:\/\/doi.org\/10.1016\/j.jsat.2013.04.002","DOI":"10.1016\/j.jsat.2013.04.002"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Walley AY, Doe-Simkins M, Quinn E, Pierce C, Xuan Z, Ozonoff A. Opioid overdose prevention with intranasal naloxone among people who take methadone. J Subst Abuse Treat. 2013;44(2):241-247. https:\/\/doi.org\/10.1016\/j.jsat.2012.07.004","DOI":"10.1016\/j.jsat.2012.07.004"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Uebelacker LA, Bailey G, Herman D, Anderson B, Stein M. Patients' beliefs about medications are associated with stated preference for methadone, buprenorphine, naltrexone, or no medication-assisted therapy following inpatient opioid detoxification. J Subst Abuse Treat. 2016;66:48-53. https:\/\/doi.org\/10.1016\/j.jsat.2016.02.009","DOI":"10.1016\/j.jsat.2016.02.009"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Doran KM, Rahai N, McCormack RP, et al. Substance use and homelessness among emergency department patients. Drug Alcohol Depend. 2018;188:328-333. https:\/\/doi.org\/10.1016\/j.drugalcdep.2018.04.021","DOI":"10.1016\/j.drugalcdep.2018.04.021"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Feelemyer J, Des Jarlais D, Arasteh K, Abdul-Quader AS, Hagan H. Retention of participants in medication-assisted programs in low- and middle-income countries: An international systematic review. Addiction. 2014;109(1):20-32. https:\/\/doi.org\/10.1111\/add.12303","DOI":"10.1111\/add.12303"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Scheibe A, Marks M, Shelly S, Gerardy T, Domingo AK, Hugo J. Developing an advocacy agenda for increasing access to opioid substitution therapy as part of comprehensive services for people who use drugs in South Africa. S Afr Med J. 2018;108(10):800-802. https:\/\/doi.org\/10.7196\/SAMJ.2018.v108i10.13397","DOI":"10.7196\/SAMJ.2018.v108i10.13397"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Scheibe A, Shelly S, Gerardy T, et al. Six-month retention and changes in quality of life and substance use from a low-threshold methadone maintenance therapy programme in Durban, South Africa. Addict Sci Clin Pract. 2020;15(1):13. https:\/\/doi.org\/10.1186\/s13722-020-00186-7","DOI":"10.1186\/s13722-020-00186-7"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Marcus TS, Heese J, Scheibe A, et al. Harm reduction in an emergency response to homelessness during South Africa's COVID-19 lockdown. Harm Reduct J. 2020;17(1):60. https:\/\/doi.org\/10.1186\/s12954-020-00404-0","DOI":"10.1186\/s12954-020-00404-0"}],"container-title":["South African Family Practice"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T08:35:25Z","timestamp":1744792525000},"score":1,"resource":{"primary":{"URL":"https:\/\/safpj.co.za\/index.php\/safpj\/article\/view\/5708"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,14]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,7,14]]}},"URL":"https:\/\/doi.org\/10.4102\/safp.v65i1.5708","relation":{},"ISSN":["2078-6204","2078-6190"],"issn-type":[{"type":"electronic","value":"2078-6204"},{"type":"print","value":"2078-6190"}],"subject":[],"published":{"date-parts":[[2023,7,14]]}}}